Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hugh Grosvenor, The Duke of Westminster, has donated £1m towards Oxford University’s COVID-19 mental health research programmes. This is part of the £10m donation announced by the Westminster Foundation last month to support the national COVID-19 relief effort.

Teenage girl sad and thoughtful looking out of a window

The grant will be made available through the Westminster Foundation to support the University’s Department of Psychiatry, which is at the forefront of mental health research in the UK. They are addressing a broad range of mental health issues arising from the pandemic and its impacts on the human psyche, including isolation, confinement, uncertainty, anxiety, stress and the disconnection from our social, family and work lives.

The effect of the pandemic on the mental well-being of children is of particular concern and interest to the Duke, and Westminster Foundation, which provides long-term support to vulnerable young people and families.

The University’s mental health researchers are developing diagnostic tools and crafting expert guidance for governments, schools, parents, medical professionals, therapists, carers and individuals. For example, Oxford is working with thousands of local families to track children and young people’s mental health throughout the COVID-19 crisis. The results will help researchers identify what protects children and young people from deteriorating mental health over time and at particular stress points, and how this may vary according to child and family characteristics. A team of psychiatrists and researchers are also developing a set of resources to help communicate parental illness and death to children.

Read the full story on the University of Oxford website

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.